INTERNATIONAL PATENT: GENENTECH, INC. FILES APPLICATION FOR "METHODS FOR TREATMENT OF PANCREATIC CANCER WITH ANTI-PD-L1 AB, ANTI-TIGIT AB, GEMCITABINE AND NAB-PLACLITAXEL"

GENEVA, Aug. 26 -- GENENTECH, INC. (1 DNA WaySouth San Francisco, CA 94080-4990) filed a patent application (PCT/US2025/015674) for "METHODS FOR TREATMENT OF PANCREATIC CANCER WITH ANTI-PD-L1 AB, ANTI-TIGIT AB, GEMCITABINE AND NAB-PLACLITAXEL" on Feb 13, 2025. With publication no. WO/2025/174933, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAU, Janet (1 DNA WaySouth San Francisco, CA 94080-4990), PRIZANT, Hen (1 DNA WaySouth San Francisco, CA 94080-4990), CHA, Edward, Namserk (1 DNA WaySouth San Francisco, CA 94080-49...